Jivi

Product Overview

About Jivi

Jivi is a prescription medicine used under the supervision of a doctor who has experience in the treatment of haemophilia.

What it is used for

Not available in the source facts.

How it is used

Jivi is given by injection into a vein. The dose and frequency of treatment depend on whether it is used to treat or prevent bleeding, as well as on the severity of the haemophilia, the extent and location of the bleeding and the patient’s condition and weight. Patients or their carers may be able to inject Jivi themselves at home once they have been trained appropriately.

How it works

Patients with haemophilia A lack factor VIII, a protein needed for blood to clot and, as a result, they bleed readily. The active substance in Jivi, damoctocog alfa pegol, is a man-made version of factor VIII and works in the same way as the body’s factor VIII. It replaces the missing factor VIII, thereby helping the blood to clot and giving temporary control of the bleeding disorder. In Jivi, the factor VIII is attached to a substance called polyethylene glycol (PEG), which helps the medicine remain in the body for longer, thereby prolonging its action and allowing it to be given less often.

Active substance: damoctocog alfa pegol

Source: EMA EPAR